Developmental and Epileptic Encephalopathy 17: Clinical Trials

1 trial for Developmental and Epileptic Encephalopathy 17, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Developmental and Epileptic Encephalopathy 17: new trials by email Literature Review of Developmental and Epileptic Encephalopathy 17 trials Research Report on Developmental and Epileptic Encephalopathy 17

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prospective Pilot Trial to Address Feasibility and Safety of Oral Zinc in GNAO1 Associated Disorders
Zinc Acetate Dihydrate - GNAO1, Dystonia
Phase 2CompletedChildren's University Hospital Cologne, Germany132024-08-022026-02-03

Narrower conditions

Dystonia (1)  ·  Epilepsy (1)  ·  Learning Disabilities (1)

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Communication Disorders (1)  ·  Dyskinesias (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurodevelopmental Disorders (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Zinc Acetate (1)

Sponsors

Children's University Hospital Cologne, Germany (1)

Countries

Germany (1)

Top investigators

Moritz Thiel, MD (1)

Results publications

PMID 40277885, PMID 42542632